Ethicon Endo-Surgery

Clinical trials sponsored by Ethicon Endo-Surgery, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

A subsidiary of Johnson & Johnson focused on surgical devices and wound closure products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Can a smarter stapler reduce surgical leaks and bleeding?

Disease control Not yet recruiting

This trial is testing whether the ETHICON 4000 stapler system works better than standard staplers during stomach and lung surgeries. The study will compare how often air leaks and bleeding occur along the staple line, as well as side effects within 30 days after surgery. About 30…

Sponsor: Ethicon Endo-Surgery • Aim: Disease control

Last updated Sep 05, 2026 00:00 UTC

Ethicon Endo-Surgery

Can a smarter stapler reduce surgical leaks and bleeding?